The groundbreaking rise of Viagra has consistently remained a symbol of pharmaceutical success, yet its future within the broader industry now presents questions about potential returns . Copycat versions are eroding market share, leading to anxieties that investing in companies significantly dependent to Viagra's once-dominant standing could be a